French Medical Device Firm Pays $1.2M in US Foreign Bribery Probe; Executives Indicted
Balt SAS, a medical device company headquartered in France, has resolved a bribery investigation led by the U.S. Department of Justice involving illegal payments to a top physician at a state-owned French hospital. Under the Foreign Corrupt Practices Act (FCPA), Balt voluntarily disclosed the misconduct, cooperated with investigators, and agreed to pay $1.2 million in disgorgement, avoiding prosecution. The scheme reportedly spanned several years, with bribes aimed at securing business advantages for the company in the French healthcare sector. Two individuals, a healthcare executive and a sales consultant, have been indicted in connection with the case, underscoring prosecution efforts targeting... [Continue Reading]
360LiveNews | 19 Mar 2026 19:15
